RiabniActive Ingredient(s): Rituximab-arrx
FDA Approved: * December 17, 2020
Pharm Company: * AMGEN INC
Rituximab, sold under the brand name Rituxan among others, is a monoclonal antibody medication used to treat certain autoimmune diseases and types of cancer. It is used for non-Hodgkin lymphoma, chronic lymphocytic leukemia (in non-geriatric patients), rheumatoid arthritis, granulomatosis with polyangiitis, idiopathic thrombocytopenic purpura, pemphigus vulgaris, myasthenia gravis and Epstein–Barr virus-positive mucocutaneous ulcers.[10&... [wikipedia]* May have multiple approval dates, manufacturers, or labelers.